|
|
| (69 intermediate revisions by 3 users not shown) |
| Line 1: |
Line 1: |
| {{Navbox | | {{#ask: [[Is DrugClass::Benzodiazepine]] | ?SeizureDose=Dose | ?BrandName=Trade Name}} |
| | name = Clinically Relevant Bacteria
| |
| | title = [[Microbiology (Main)|Disease-Causing Bacteria]]
| |
| | state = {{{state|autocollapse}}} | |
| |listclass = hlist
| |
| | groupstyle = background:PowderBlue;
| |
|
| |
|
| |group1 = [[Gram Negatives]]
| | [[Scarlet_fever_1.2.jpg|thumb|"Slapped cheeks" and "white mustache" (circumoral pallor) typical of scarlet fever.]] |
| |list1 = {{Navbox subgroup
| |
|
| |
|
| }}
| | We heard you. '''Our native WikEM app is back!''' Download from your app store now ([http://apps.apple.com/us/app/wikem/id576405449 iOS] and [https://play.google.com/store/apps/details?id=wikem.chris Android]). |
| }}
| |
|
| |
|
| ==Clinical Features==
| | [http://mediawiki.org MediaWiki] |
| *Absence of GI symptoms within 6hr of ingestion excludes significant iron ingestion (exception: enteric coated tablets)
| |
| *Significant iron toxicity can result in a severe [[lactic acidosis]] from hypoperfusion due to volume loss, vasodilation and negative inotropin effects.
| |
|
| |
|
| {| class="wikitable"
| | [http://apps.apple.com App] |
| |+ Iron Toxicity Stages
| |
| |-
| |
| ! scope="col" | '''Staging'''
| |
| ! scope="col" | '''Clinical Effect'''
| |
| ! scope="col" | '''Time Frame'''
| |
| |-
| |
| | Stage 1||GI irritation: nausea and vomiting, abdominal pain, diarrhea||30 mins-6 hours
| |
| |-
| |
| | Stage 2: Latent||Reduced GI symptoms||6-24 hours
| |
| |-
| |
| | Stage 3: Shock and metabolic acidosis||Metabolic acidosis, lactic acidosis, dehydration||6-72 hours
| |
| |-
| |
| | Stage 4: Hepatotoxicity/ Hepatic necrosis||Hepatic failure||12-96 hours
| |
| |-
| |
| | Stage 5: Bowel obstruction||GI mucosa healing leads to scarring||2-8 weeks
| |
| |}
| |
|
| |
|
| *Stage I: GI toxicity: nausea, vomiting, diarrhea, GI bleeding from local corrosive effects of iron on the gastric and intestinal mucosa
| | [https://apps.apple.com App] |
| *Stage II: Quiescent phase with resolution of GI symptoms and apparent clinical improvement
| |
| **controversy between toxicologists whether this stage exists in significant poisonings
| |
| *Stage III: Systemic toxicity: shock and hypoperfusion
| |
| **Primarily hypovolemic shock and acidosis, myocardial dysfunction also contributes
| |
| **GI fluid losses, increase capillary permeability, decreased venous tone
| |
| **Severe anion gap acidosis
| |
| **Free radical damage to mitochondria disrupt oxidative phosphorylation which leads to lactic acidosis
| |
| **Hepatotoxicity from iron delivery via portal blood flow
| |
| *Stage IV: Clinical recovery, resolution of shock and acidosis usually by days 3-4
| |
| *Stage V: Late onset of gastric and pyloric strictures (2-8 week later) <ref> Fine, J. Iron Poisoning. Curr Probl Pediatr, Vol 30, Iss 3, p 71-90, March 2000 </ref>
| |
|
| |
|
| {| class="wikitable"
| | [http://apps.apple.com/us/app/wikem/id576405449 iOS] |
| |+ CDC management guidelines for children with elevated blood levels<ref name="Kosnett06-242">[[#CITEREFKosnett06Pois|Kosnett (2006)]] p. 242</ref>
| | |
| ! scope="col" | '''Blood lead level (μg/dL)'''
| | [https://apps.apple.com/us/app/wikem/id576405449 https://play.google.com/store/apps/details?id=wikem.chris iOS] |
| ! scope="col" | '''Treatment'''
| |
| |-
| |
| | 10–14
| |
| | Education, repeat screening
| |
| |-
| |
| | 15–19
| |
| | Repeat screening, case management to abate sources
| |
| |-
| |
| | 20–44
| |
| | Medical evaluation, case management
| |
| |-
| |
| | 45–69
| |
| | Medical evaluation, chelation, case management
| |
| |-
| |
| | >69
| |
| | Hospitalization, immediate chelation, case management
| |
| |}
| |
